The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...

Nicholas P. Gall, M.Sc., M.D., M.R.C.P.; Francis D. Murgatroyd, M.A., F.R.C.P., F.A.C.C. From these and subsequent studies, it became clear that cardioversion was ...

Patients with recent-onset atrial fibrillation commonly undergo immediate restoration of sinus rhythm by pharmacologic or electrical cardioversion. However, whether immediate restoration of sinus ...

Direct current cardioversion for symptomatic atrial fibrillation or flutter is feasible and safe in patients implanted with the Watchman left atrial appendage (LAA) occlusion device, even in the ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...

A small series provides provocative new data on the safety of performing direct current cardioversion (DCCV) without oral anticoagulation in high-risk patients with a Watchman left atrial appendage ...

Atrial fibrillation (AFib) is a kind of irregular heartbeat, or arrhythmia. A problem with the electrical signals that control your heart’s pumping action causes it to beat too fast in a pattern that ...

Hubner and colleagues in the UK have recently described a simplified cardioversion service that has significantly reduced waiting times at their center. They have introduced intravenous midazolam ...

Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...

Electrical cardioversion without routine extra anticoagulation around the procedure may be feasible for people who've already received left atrial appendage (LAA) occlusion, according to a small ...